RADAR-AD project announces one-year extension


Earlier this year (in May) the RADAR-AD consortium was granted a one-year extension to make up for delay caused by the COVID-19 pandemic. RADAR-AD aims to find new digital biomarkers for cognition and function in people living with Alzheimer’s disease. Due to the restrictions surrounding the COVID-19 pandemic, enrolment of research participants in the RADAR-AD clinical studies was severely hampered. The need for a project extension was therefore clear to all consortium members, and after making some adjustments in the project timeline as well as in the budgets, a new RADAR-AD end date was agreed upon: the new project end date is 30 June 2023. Find out more here